LARIXIME 1.2

bt_bb_section_bottom_section_coverage_image

Composition

Amoxycillin 1g & Potassium Clavulanate 200mg

Trusted Strength Against Tough Infections

Indication:
Larixime 1.2gm is indicated for the treatment of a wide range of bacterial infections, particularly those caused by beta-lactamase-producing organisms. It is highly effective in the following conditions:

  • Tonsillitis: Inflammation of the tonsils caused by bacterial infections.
  • Otitis Media: Middle ear infections, especially in pediatric patients.
  • Sinusitis: Bacterial sinus infections, reducing symptoms and preventing complications.
  • Chronic Bronchitis: Management of bacterial exacerbations in patients with chronic bronchitis.
  • Community-Acquired Pneumonia (CAP): Treatment of pneumonia caused by S. pneumoniae, H. influenzae, S. aureus, and M. catarrhalis.
  • Urinary Tract Infections (UTIs): Treatment of uncomplicated and complicated UTIs.
  • Skin & Soft Tissue Infections: Effective against cellulitis, abscesses, and wound infections.
  • Surgical Prophylaxis: Used to prevent post-surgical infections in patients undergoing certain procedures.

Mode of Action:
Larixime 1.2gm combines the broad-spectrum antibiotic Amoxycillin with Potassium Clavulanate, a beta-lactamase inhibitor.

  • Amoxycillin works by inhibiting bacterial cell wall synthesis, which is essential for bacterial growth and replication. By disrupting cell wall formation, amoxycillin effectively kills susceptible bacteria.
  • Potassium Clavulanate protects amoxycillin from degradation by beta-lactamase enzymes produced by resistant bacteria, thereby extending the antibiotic’s spectrum of activity. This combination makes Larixime 1.2gm effective against a broader range of bacteria, including those that produce beta-lactamase.

Clinical Efficacy:
According to studies published in Clinical Infectious Disease, the Amoxycillin/Potassium Clavulanate combination is both effective and safe for treating lower respiratory tract infections, such as community-acquired pneumonia caused by S. pneumoniae and H. influenzae, as well as acute exacerbations of chronic bronchitis due to M. catarrhalis.

How to Take Larixime 1.2gm:

  • Administration: Larixime 1.2gm is administered as an intravenous (IV) or intramuscular (IM) injection. It is typically given by a healthcare professional in a clinical setting.
  • Reconstitution: The powder should be reconstituted with the appropriate diluent before administration, following the manufacturer’s instructions or healthcare provider’s guidance.
  • Timing: The dosing frequency depends on the severity of the infection. Mild to moderate infections are generally treated with injections three times a day, while severe infections may require four injections per day.

Dosage:

  • Mild to Moderate Infections: Administer Larixime 1.2gm three times a day.
  • Severe Infections: Administer Larixime 1.2gm four times a day.

Possible Side Effects:
While Larixime 1.2gm is generally well-tolerated, some patients may experience side effects. Common side effects include:

  • Injection Site Reactions: Pain, swelling, or redness at the injection site.
  • Gastrointestinal Issues: Nausea, vomiting, diarrhea, or abdominal discomfort. Taking the medication with food may help alleviate these symptoms.
  • Allergic Reactions: Rash, itching, or hives. Severe allergic reactions (anaphylaxis) are rare but require immediate medical attention.
  • Hematologic Changes: Rarely, the combination may cause changes in blood counts, such as leukopenia, thrombocytopenia, or anemia. Regular monitoring may be required during prolonged therapy.
  • Liver Enzyme Elevations: Transient increases in liver enzymes (AST, ALT) may occur. Liver function should be monitored, particularly in patients with pre-existing liver conditions.
  • Yeast Infections: Prolonged use of antibiotics can sometimes lead to the overgrowth of non-susceptible organisms, such as yeast.

Precautions:

  • Renal and Hepatic Function: Use with caution in patients with renal or hepatic impairment. Dose adjustments may be necessary.
  • Allergic Reactions: Patients with a history of allergies to penicillins or other beta-lactam antibiotics should use Larixime 1.2gm with caution.
  • Drug Interactions: Inform your healthcare provider of all medications you are taking, as Larixime 1.2gm can interact with certain drugs.
  • Superinfection Risk: Monitor for signs of secondary infections due to prolonged antibiotic use.

Consult Your Doctor:

  • Before starting Larixime 1.2gm if you have any known allergies, particularly to beta-lactam antibiotics, or if you have liver or kidney disease.
  • If you experience any severe or unusual symptoms, particularly signs of an allergic reaction or gastrointestinal distress.
  • For guidance on the proper use of Larixime 1.2gm and to discuss any concerns regarding your treatment plan.

Disclaimer: This information is for general knowledge only and should not be considered medical advice. Always consult with a healthcare professional for personalized guidance.

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2023/08/LARIXIME-1.2.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved